Blood glucose response after oral lactulose intake in type 2 diabetic individuals.

ABSTRACT:

Background

Lactulose is approved for the symptomatic treatment of constipation, a gastrointestinal (GI) complication common in individuals with diabetes. Lactulose products contain carbohydrate impurities (e.g., lactose, fructose, galactose), which occur during the lactulose manufacturing process. These impurities may affect the blood glucose levels of individuals with type 2 diabetes mellitus (T2DM) using lactulose for the treatment of mild constipation. A previous study in healthy subjects revealed no increase in blood glucose levels after oral lactulose intake. However, it is still unclear whether the intake of lactulose increases blood glucose levels in individuals with diabetes.

Aim

To evaluate the blood glucose profile after oral lactulose intake in mildly const

SUBMITTER: Pieber TR 

PROVIDER: S-EPMC8192256 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature